← Back to Search

Cognitive Behavioral Therapy for Scoliosis (PASS Trial)

N/A
Recruiting
Led By Eric D Fornari, MD
Research Sponsored by Montefiore Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up preoperatively (baseline), and postoperatively at 6 weeks, 6 months, and 1 year after surgery for both the standard of care control group and psychological intervention group
Awards & highlights
No Placebo-Only Group

Summary

This trial will study AIS patients to understand how to reduce anxiety and pain with evidence-based cognitive behavioral therapy protocols.

Who is the study for?
This trial is for healthy, non-obese young people aged 12-19 with a diagnosis of idiopathic scoliosis who are about to have elective posterior spinal fusion surgery. They should be diagnosed before age 20 and will undergo mental health, pain, and function assessments.
What is being tested?
The study tests the ADAPT program—a psychological intervention based on cognitive behavioral therapy—to see if it can reduce anxiety and pain in patients undergoing scoliosis surgery. Participants are randomly assigned to receive this intervention or not.
What are the potential side effects?
Since ADAPT is a psychological intervention based on cognitive behavioral therapy, there may not be direct physical side effects like those seen with medications; however, participants might experience emotional discomfort during therapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~preoperatively (baseline), and postoperatively at 6 weeks, 6 months, and 1 year after surgery for both the standard of care control group and psychological intervention group
This trial's timeline: 3 weeks for screening, Varies for treatment, and preoperatively (baseline), and postoperatively at 6 weeks, 6 months, and 1 year after surgery for both the standard of care control group and psychological intervention group for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Assessment of changes in Mental health preoperatively and post postoperatively using the Patient Health Questionnaire (PHQ)-9.
Assessment of changes in Mental health preoperatively and postoperatively using Generalized Anxiety Disorder (GAD-7)
Assessment of changes in Mental health preoperatively and postoperatively using PROMIS- (Patient-Reported Outcomes Measurement Information System) short form for Depression
+2 more
Secondary study objectives
Assessment of changes in Function score preoperatively and postoperatively using Scoliosis Research Society questionnaire-22 revised (SRS-22r) for adolescents with idiopathic scoliosis
Assessment of changes in Satisfaction with management score preoperatively and postoperatively using Scoliosis Research Society questionnaire-22 revised (SRS-22r) for adolescents with idiopathic scoliosis
Assessment of changes in mental health preoperatively and postoperatively using Scoliosis Research Society questionnaire-22 revised (SRS-22r) for adolescents with idiopathic scoliosis
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: psychological intervention ADAPTExperimental Treatment1 Intervention
The psychological intervention plan is based on the Aim to Decrease Anxiety and Pain Treatment (ADAPT) model.
Group II: standard of care control groups no psychological interventionActive Control1 Intervention
standard of care control groups no psychological intervention

Find a Location

Who is running the clinical trial?

Albert Einstein College of MedicineOTHER
296 Previous Clinical Trials
11,688,833 Total Patients Enrolled
Montefiore Medical CenterLead Sponsor
458 Previous Clinical Trials
588,494 Total Patients Enrolled
Eric D Fornari, MDPrincipal InvestigatorMontefiore Medical Center
~72 spots leftby Oct 2026